Literature DB >> 33319323

Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).

Cinthia Castro do Nascimento1, Odair Aguiar2, Gustavo Monteiro Viana3, Vânia D'Almeida4.   

Abstract

Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease caused by a mutation in the IDUA gene, which codes α-L-iduronidase (IDUA), a lysosomal hydrolase that degrades two glycosaminoglycans (GAGs): heparan sulfate (HS) and dermatan sulfate (DS). GAGs are macromolecules found mainly in the extracellular matrix and have important signaling and structural roles which are essential to the maintenance of cell and tissue physiology. Nondegraded GAGs accumulate in various cell types, which characterizes MPS I as a multisystemic progressive disease. Many tissues and vital organs have been described in MPS I models, but there is a lack of studies focused on their effects on the reproductive tract. Our previous studies indicated lower sperm production and morphological damage in the epididymis and accessory glands in male MPS I mice, despite their ability to copulate and to impregnate females. Our aim was to improve the testicular characterization of the MPS I model, with a specific focus on ultrastructural observation of the different cell types that compose the seminiferous tubules and interstitium. We investigated the testicular morphology of 6-month-old male C57BL/6 wild-type (Idua+/+) and MPS I (Idua-/-) mice. We found vacuolated cells widely present in the interstitium and important signs of damage in myoid, Sertoli and Leydig cells. In the cytoplasmic region of Sertoli cells, we found an increased number of vesicles with substrates under digestion and a decreased number of electron-dense vesicles similar to lysosomes, suggesting an impaired flux of substrate degradation. Conclusions: Idua exerts an important role in the morphological maintenance of the seminiferous tubules and the testicular interstitium, which may influence the quality of spermatogenesis, having a greater effect with the progression of the disease.

Entities:  

Keywords:  Interstitium; Lysosome; Mucopolysaccharidosis; Myoid; Sertoli; Testis

Mesh:

Substances:

Year:  2020        PMID: 33319323     DOI: 10.1007/s11033-020-06055-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

1.  Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.

Authors:  Patricia I Dickson; N Matthew Ellinwood; Jillian R Brown; Robert G Witt; Steven Q Le; Merry B Passage; Moin U Vera; Brett E Crawford
Journal:  Mol Genet Metab       Date:  2012-02-08       Impact factor: 4.797

2.  Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy.

Authors:  M Castorina; D Antuzzi; S M Richards; G F Cox; Y Xue
Journal:  Clin Exp Obstet Gynecol       Date:  2015       Impact factor: 0.146

3.  Altered Cellular Homeostasis in Murine MPS I Fibroblasts: Evidence of Cell-Specific Physiopathology.

Authors:  Gustavo Monteiro Viana; Cinthia Castro do Nascimento; Edgar Julian Paredes-Gamero; Vânia D'Almeida
Journal:  JIMD Rep       Date:  2017-02-21

4.  Enzyme-replacement therapy in mucopolysaccharidosis I.

Authors:  E D Kakkis; J Muenzer; G E Tiller; L Waber; J Belmont; M Passage; B Izykowski; J Phillips; R Doroshow; I Walot; R Hoft; E F Neufeld
Journal:  N Engl J Med       Date:  2001-01-18       Impact factor: 91.245

5.  Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis.

Authors:  Vanessa Gonçalves Pereira; Marcos L Gazarini; Lara Cheliz Rodrigues; Flávia Helena da Silva; Sang Won Han; Ana Maria Martins; Ivarne L S Tersariol; Vânia D'Almeida
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

6.  Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.

Authors:  Kazuhiro Ohmi; David S Greenberg; Kavitha S Rajavel; Sergey Ryazantsev; Hong Hua Li; Elizabeth F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

7.  Analysis of male reproductive parameters in a murine model of mucopolysaccharidosis type I (MPS I).

Authors:  Cinthia Castro do Nascimento; Odair Aguiar Junior; Vânia D'Almeida
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice.

Authors:  Gustavo Monteiro Viana; Marcus Vinícius Buri; Edgar Julian Paredes-Gamero; Ana Maria Martins; Vânia D'Almeida
Journal:  J Cell Physiol       Date:  2016-03       Impact factor: 6.384

9.  Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice.

Authors:  Guilherme Baldo; Fabiana Quoos Mayer; Barbara Martinelli; Anna Dilda; Fabiola Meyer; Katherine P Ponder; Roberto Giugliani; Ursula Matte
Journal:  Behav Brain Res       Date:  2012-05-09       Impact factor: 3.332

10.  Pregnancy in patients with mucopolysaccharidosis: a case series.

Authors:  Fiona J Stewart; Andrew Bentley; Barbara K Burton; Nathalie Guffon; Susan L Hale; Paul R Harmatz; Susanne G Kircher; Pavan K Kochhar; John J Mitchell; Ursula Plöckinger; Sue Graham; Stephen Sande; Zlatko Sisic; Tracey A Johnston
Journal:  Mol Genet Metab Rep       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.